gdc
Submit Your Story
Subscribe

Ovarian Cancer

Zejula Approved for HRD-Positive Advanced Ovarian Cancer
Ovarian Cancer
Zejula Approved for HRD-Positive Advanced Ovarian Cancer
December 2019 Vol 5 No 6
Late last year, the PARP inhibitor Zejula was approved by the FDA for patients with HRD mutation associated with advanced ovarian, fallopian tube, or primary peritoneal cancer, offering a new treatment option for women with these types of cancer.
Ovarian Cancer Patient Advocacy Organizations
Ovarian Cancer
Ovarian Cancer Patient Advocacy Organizations
Web Exclusives
There are a number of excellent organizations providing resources and support to you as a patient with ovarian cancer or a caregiver.
Ovarian Cancer: Progress Occurs, but Far Too Slowly
Ovarian Cancer
Ovarian Cancer: Progress Occurs, but Far Too Slowly
By Annette Bennington McElhiney, PhD
October 2019 Vol 5 No 5
As a retired college professor, Dr. McElhiney uses her personal experience with ovarian cancer to advocate for other patients, urging faster development of new treatment options.
Finding Strength in Cancer Planning: How a Cancer Diagnosis Changed the Life Path of Sharon Kim, Creator of CanPlan
Ovarian CancerThe Empowered Patient
Finding Strength in Cancer Planning: How a Cancer Diagnosis Changed the Life Path of Sharon Kim, Creator of CanPlan
By Kristen Chanley
September 2019 Volume 5 – Women's Health
What on Earth Is a “Biomarker”?
Ovarian CancerCancer BiomarkersCancer ScreeningIssue Introductions
What on Earth Is a “Biomarker”?
By Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
May 2019 Volume 5 – Biomarkers & Molecular Testing
In her Introduction to the special edition of CONQUER titled Understanding Biomarkers & Molecular Testing, Lillie D. Shockney, RN, BS, MAS, ONN-CG, briefly explains what biomarkers are, why they are important, and what you should know about them.  
Who Should Be Screened for Cervical or Ovarian Cancers?
Cancer ScreeningCervical CancerGynecologic CancersOvarian Cancer
Who Should Be Screened for Cervical or Ovarian Cancers?
By Julian Schink, MD
October 2018 Vol 4 No 5
Dr. Julian Schink, GYN Oncology Chief of Cancer Treatment Centers of America, provides screening tips and recommendations for these 2 most common gynecologic cancers.
Lynparza Approved as Maintenance Treatment for Ovarian Cancer
FDA Approvals, News & UpdatesGynecologic CancersNewsworthyOvarian Cancer
Lynparza Approved as Maintenance Treatment for Ovarian Cancer
December 2017 Vol 3 No 6
In August 2017, the FDA approved Lynparza tablets for the maintenance treatment of adults with recurrent epithelial ovarian, fallopian tube, or peritoneal cancer who had a response to platinum-based chemotherapy.
What You Need to Know About Ovarian Cancer
Gynecologic CancersOvarian Cancer
What You Need to Know About Ovarian Cancer
By Cheryl Bellomo, MSN, RN, OCN, HON-ONN-CG
October 2016 Vol 2 No 5
Ovarian cancer ranks fifth in cancer-related deaths in women, accounting for more deaths than any other cancer of the female reproductive system.
5 Lessons from an Ovarian Cancer Survivor
Gynecologic CancersOvarian Cancer
5 Lessons from an Ovarian Cancer Survivor
By Marcia Donziger
October 2016 Vol 2 No 5
In 1997 I was 27, happy, free, and traveling the world as a flight attendant. Newly married and ready to have a baby, I felt strong and invincible. My future was unfolding just as I expected it to. Until the symptoms appeared ever so subtly.
When Cancer Runs in Your Family
Gynecologic CancersOvarian CancerPatient Stories
When Cancer Runs in Your Family
By Roberta Aberle
February 2016 Vol 2 No 1
A look at how Roberta Aberle deals with the fact that cancer runs in her family.
  • 1
  • 2
Page 1 of 2
Results 1 - 10 of 13

Subscribe to CONQUER™: the patient voice™ magazine

Receive timely cancer news & updates, patient stories, and more.

Country